Search
for
Sort by
Research 751–780 of 1000+
- Activator Protein-1 Activity Regulates Epithelial Tumor Cell Identity
- Neuroendocrine Perspectives in Alopecia Areata: Does Stress Play a Role?
- Development of Alopecia Areata Universalis in a Patient Receiving Adalimumab
- Alopecia areata − animal models
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
- Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study
- Trichohyalin is a Potential Major Autoantigen in Human Alopecia Areata
- Biomarkers of alopecia areata disease activity and response to corticosteroid treatment
- Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review
- CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata
- A Large Cross-Sectional Survey Study of the Prevalence of Alopecia Areata in the United States
- JAK Inhibitors for Treatment of Alopecia Areata
- The Role of Micronutrients in Alopecia Areata: A Review
- Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: A trichoscopic evaluation
- Imbalance of T‐helper 17 and regulatory T cells in patients with alopecia areata
- The genetics of alopecia areata: New approaches, new findings, new treatments
- Oxidative Stress in Alopecia Areata: A Case–Control Study
- Transcriptional profiling in alopecia areata defines immune and cell cycle control related genes within disease-specific signatures
- Alopecia areata as another immune‐mediated disease developed in patients treated with tumour necrosis factor‐α blocker agents
- The role of lymphocytes in the development and treatment of alopecia areata
- Alopecia areata incognita: A Hypothesis
- Failure of passive transfer of serum from patients with alopecia areata and alopecia universalis to inhibit hair growth in transplants of human scalp skin grafted on to nude mice
- The C3H/HeJ mouse and DEBR rat models for alopecia areata: review of preclinical drug screening approaches and results
- Review of quality of life studies in women with alopecia
- Platelet-rich plasma as a potential treatment for noncicatricial alopecias
- Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study
- Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata
- Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease‐associated psychological morbidity
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata